Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 5, 2014
[Levodopa: the story continues]N V Titova, E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 15, 2015
[Current possibilities of quality of life improvement in the late stages of Parkinson's disease]N V Titova, E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 14, 2023
[Asthenia, mental fatigue and cognitive dysfunction]N V Titova, Yu N Bezdolny, E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 8, 2016
[Comorbid states in Parkinson's disease: an effect of MAO-B inhibitors]N V Titova, E A Katunina, N N SotnikovaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 17, 2021
[Restless legs syndrome]E A Katunina, N V Titova, D A Katunin, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 24, 2022
[The problem of pharmacoresistant tremor in Parkinson's disease and essential tremor]N V Titova, E A Katunina, R T Tairova, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 1, 2018
[A clinical and genetic study of impulsive-compulsive disorders in patients with Parkinson's disease]N N Shipilova, N V Titova, Z G Kokaeva, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 19, 2019
[Creativity in patients with Parkinson's disease]E A Katunina, N N Shipilova, N V Titova, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 26, 2021
[Amantadine in the treatment of Parkinson's disease. New opportunities in the context of COVID-19]E A KatuninaEksperimental'Naia I Klinicheskaia Farmakologiia|November 10, 2005
[Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis]E A KatuninaPageof 5